Equity Research Associate – Immuno-Oncology

LE001 Leerink Partners LLC; New York (NY); On-site; USD 135,000 - 170,000; Full time

Job summary

Leerink Partners LLC in New York is seeking an Equity Research Associate – Immuno-Oncology to work with senior analysts on cancer immunotherapy programs, spanning cell therapy to traditional modalities and covering multiple company sizes. You will collect primary data, build and maintain models, and develop investment ideas while monitoring regulatory, clinical, and market developments.

A PhD/MD or related Master’s and strong quantitative skills are required, with a focus on rigorous primary

Qualifications

• Advanced degree in a relevant scientific/quantitative field (PhD/MD or related Master’s).
• Strong quantitative and analytical skills; hands-on experience with statistical or simulation-based analysis.

Responsibilities

• Collect and analyze primary data and expert opinion related to cancer immunotherapy.
• Maintain and analyze a database of ongoing cancer immunotherapy trials, including revenue and commercial simulations.
• Build, update, and maintain financial models.
• Formulate investment recommendations based on fundamental analysis, valuation, and risk assessment of individual companies.
• Write research reports and notes on companies, immunotherapy mechanisms and modalities, and specific cancer settings for institutional clients and corporate audiences.
• Stay current on relevant company, market, scientific, clinical, and regulatory developments.
• Support senior equity research professionals at medical and scientific conferences, including preparation, attendance, and post-conference analysis.
• Respond to inquiries from firm personnel and clients.

Skills

Advanced degree

Financial modeling

Excel skills

Statistical/simulation analysis

Communication skills

Biotech/pharma knowledge

AI tools in research

Education

PhD/MD or related Master’s

Tools

Excel

Access

Job description

Title: Equity Research Associate – Immuno-Oncology

Reports to: Senior Equity Research Analyst

Department: Equity Research

Location: New York

Salary Range: $135,000–$170,000

About the Role This individual will work closely with senior equity research professionals on scientific, clinical, commercial, financial, and strategic assessments of companies developing cancer immunotherapies — from cell therapy to traditional modalities, and small/mid-cap to large-cap biopharmaceutical companies. While the majority of the work is focused on cancer immunotherapy, the team also covers a broader set of therapies developed by our companies, including vaccines and treatments for immunological, cardiovascular, and infectious disease. What distinguishes this team from typical sell-side coverage is depth and rigor: we build our own primary analyses of clinical trial design and biostatistics rather than relying on secondary summaries, run simulation-based revenue and commercial models grounded in cohort-level assumptions, and assess clinical, regulatory (FDA/ODAC), and scientific-conference developments in our coverage and IO overall, in real time. We expect associates on this team to develop genuine subject-matter expertise — in trial methodology, mechanism of action, and market dynamics.

Primary Duties and Responsibilities

• Collect and analyze primary data and expert opinion related to cancer immunotherapy, including scientific literature, clinical trial data, and commercial infrastructure
• Maintain and analyze a database of ongoing cancer immunotherapy trials, including revenue and commercial simulations
• Build, update, and maintain financial models
• Formulate investment recommendations based on fundamental analysis, valuation, and risk assessment of individual companies
• Write research reports and notes on companies, immunotherapy mechanisms and modalities (e.g., in vivo cell therapy), and specific cancer settings, for distribution to institutional clients and corporate audiences
• Stay current on relevant company, market, scientific, clinical, and regulatory developments
• Support senior equity research professionals at medical and scientific conferences, including preparation, attendance, and post-conference analysis
• Respond to inquiries from firm personnel and clients

Experience and Qualifications

• Advanced degree: PhD, MD, or a discipline-relevant Master’s degree (e.g., pharmacology, molecular biology, physiology, bio/chem engineering, biostatistics, or another directly relevant scientific or quantitative field).
• We encourage candidates who have completed significant coursework toward a PhD or MD or bachelor's candidates with more than four years directly relevant experience to also apply.
• At least one year of relevant business experience — consulting, biopharmaceutical business development, or sell-side/buy-side equity research.
• Genuine intellectual curiosity and drive: comfortable digging into primary sources (trial protocols, scientific literature, conference data, KOL conversations) rather than secondary summaries
• Strong quantitative and analytical skills, including hands‑on experience with statistical or simulation‑based analysis (e.g., Monte Carlo/revenue simulation, survival analysis); preference for candidates with working knowledge of biostatistics and/or quantitative surveys
• Strong financial modeling, forecasting, and Excel skills; preference for candidates with Access or other database experience
• Working knowledge of the biotechnology and pharmaceutical industries, including preclinical assessment, clinical development, regulatory affairs, business development, and commercialization
• Experience with and/or enthusiasm to build processes that effectively use AI‑enabled tools to improve research, analysis, and productivity, with appropriate judgment regarding data quality, confidentiality, and verification
• Excellent written and verbal communication skills

About Leerink As the leading investment bank to the healthcare and life science industries, we help our clients move healthcare forward. With differentiated sector knowledge, unrivaled expertise, and a complete suite of capital market and advisory solutions, we are the industry’s partner of choice. Leerink Partners is a member of FINRA/SIPC. For more information, please visit: www.leerink.com.

Equal Employment Opportunity Leerink Partners is an equal opportunity employer and is dedicated to expanding its commitments and investments to create a more diverse, equitable and inclusive company culture and innovative ecosystem. We are strongly committed to the values and policy of equal employment opportunity across our employment practices. Actual starting base pay will be determined on skills, experience, and other non‑discriminatory factors permitted by law. Total compensation may also include variable incentives, bonuses, benefits, and/or other perks, as outlined in any formal offer made. At Leerink Partners, we share a common desire to achieve the highest level of success for our clients. If you are passionate about healthcare and investing, our team has unmatched access to the necessary resources and support to leverage your talents and expertise into valuable contributions for our clients. Leerink Partners is a leading investment bank providing a complete suite of financial solutions comprising M&A advisory, equity, debt, and derivative capital markets, equity research, and sales and trading capabilities. The firm’s strategic focus on the healthcare industry empowers it to provide unique advice and insights to its clients. The firm is a broker‑dealer registered with the United States Securities and Exchange Commission and a member of the Financial Industry Regulatory Authority.